Barclays Maintains an 'Equalweight' on DuPont (DD); Investor Day 2011

Barclays maintains an 'Equalweight' on DuPont (NYSE: DD) price target of $52.00.

Barclays analyst says, "1) 2012 Outlook and Guidance: DuPont sees decent macro fundamentals and continued earnings growth in '12. DuPont provided EPS guidance of $4.20-$4.40; 10% higher than the midpoint of 2011 guidance."

"2) What's really driving the ship? Growth in DuPont's Ag, Nutrition & TiO2 businesses have resulted in strong top and bottom line growth. These businesses now represent ~50% of revenue."

"3) Danisco: DuPont has continued its transformation to a more biology-driven company. Highlighting the process is the company's 2011 acquisition of Danisco, which gives DuPont greater leverage to the existing bio space."

"4) 'Q4 a Little Lower...Weakness in consumer electronics, the automotive supply chain, and PV lead to an '11E guidance revision to $3.87-$3.95 (-10c). Some of the reported weakness (electronics, PV) was expected. We have updated our Q4'11 estimates from $.48 to $.37 to reflect the aforementioned headwinds and revised our '12 EPS from $4.40 to $4.29."

For an analyst ratings summary and ratings history on DuPont click here. For more ratings news on DuPont click here.

Shares of DuPont closed at $43.49 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
• Zurn Water Solutions (ZWS) Reiterated at Buy by Stifel on New Product Development Momentum